Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines
J. Capellades(Universitat Autònoma de Barcelona), Carmen Balañá(Institut Català d'Oncologia), C. Hostalot(University of Illinois Chicago), Anna Estival(Institut Català d'Oncologia), Pilar Teixidor(Universitat de Barcelona), Juan Manuel Sepúlveda-Sánchez(Hospital Universitario 12 De Octubre), S. Villà(Institut Català d'Ornitologia), Juan Garcia(Instituto Oncológico Dr. Rosell), Santiago Medrano(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Miguel Gil‐Gil(GEICAM – Spanish Breast Cancer Group), Gerard Plans(Bellvitge University Hospital), Glòria Villalba(Universitat Pompeu Fabra)
Cited by 9
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
|Journal of Clinical Oncology|2012|645